{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:18:41Z","timestamp":1776723521392,"version":"3.51.2"},"update-to":[{"DOI":"10.1002\/14651858.cd005951.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T00:00:00Z","timestamp":1523923200000}}],"reference-count":57,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005951.pub4","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T20:50:55Z","timestamp":1523998255000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Haemostatic therapies for acute spontaneous intracerebral haemorrhage"],"prefix":"10.1002","volume":"2018","author":[{"given":"Rustam","family":"Al-Shahi Salman","sequence":"first","affiliation":[{"name":"University of Edinburgh; Centre for Clinical Brain Sciences; FU303i, First floor, Chancellor's Building 49 Little France Crescent Edinburgh Midlothian UK EH16 4SB"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe Kang","family":"Law","sequence":"additional","affiliation":[{"name":"Universiti Kebangsaan Malaysia Medical Centre; Department of Medicine; Jalan Yaacob Latif Bandar Tun Razak Kuala Lumpur Cheras Malaysia 56000"},{"name":"University of Nottingham, City Hospital; Stroke Trials Unit, Division of Clinical Neuroscience; Room B56, Clinical Sciences Building, City Hospital Campus, Nottingham UK NG5 1PB"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip M","family":"Bath","sequence":"additional","affiliation":[{"name":"University of Nottingham, City Hospital; Stroke Trials Unit, Division of Clinical Neuroscience; Room B56, Clinical Sciences Building, City Hospital Campus, Nottingham UK NG5 1PB"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Steiner","sequence":"additional","affiliation":[{"name":"Klinikum Frankfurt H\u00f6chst; Gotenstr 6-8 Frankfurt Germany 65929"},{"name":"Heidelberg University Hospital; Department of Neurology; Heidelberg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola","family":"Sprigg","sequence":"additional","affiliation":[{"name":"University of Nottingham, City Hospital; Stroke Trials Unit, Division of Clinical Neuroscience; Room B56, Clinical Sciences Building, City Hospital Campus, Nottingham UK NG5 1PB"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,4,17]]},"reference":[{"issue":"Special issue","key":"10.1002\/14651858.CD005951.pub4-BIB0001|cit1","first-page":"62","article-title":"Tranexamic acid as antifibrinolytic agent in non traumatic intracerebral hemorrhages","volume":"December","author":"Arumugam","year":"2015","journal-title":"Malaysian Journal of Medical Sciences"},{"issue":"10038","key":"10.1002\/14651858.CD005951.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","article-title":"Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial","volume":"387","author":"Baharoglu","year":"2016","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2377-10-19","article-title":"PATCH: platelet transfusion in cerebral haemorrhage: study protocol for a multicentre, randomised, controlled trial","volume":"10","author":"Gans","year":"2010","journal-title":"BMC Neurology"},{"issue":"5","key":"10.1002\/14651858.CD005951.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/00006123-199911000-00020","article-title":"Use of factor IX complex in warfarin-related intracranial hemorrhage","volume":"45","author":"Boulis","year":"1999","journal-title":"Neurosurgery"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0005|cit5","unstructured":"Novo Nordisk Randomised, double-blind, multicentre, placebo controlled dose-escalation study to evaluate the safety and preliminary efficacy of activated recombinant factor VII (NN-007) in acute intracerebral haemorrhage Unpublished 2007"},{"issue":"2","key":"10.1002\/14651858.CD005951.pub4-BIB0006|cit6","first-page":"168","article-title":"Intraoperative intravenous administration of rFVIIa and hematoma volume after early surgery for spontaneous intracerebral hemorrhage: a randomized prospective phase II study","volume":"78","author":"Imberti","year":"2012","journal-title":"Minerva Anestesiologica"},{"issue":"2","key":"10.1002\/14651858.CD005951.pub4-BIB0007|cit7","first-page":"161","article-title":"Intervention study on recombinant activated factor VIIa in depressing early hematoma extensions of cerebral hemorrhage","volume":"21","author":"Li","year":"2012","journal-title":"Chinese Journal of New Drugs"},{"issue":"1","key":"10.1002\/14651858.CD005951.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/01.STR.0000149628.80251.b8","article-title":"Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage","volume":"36","author":"Mayer","year":"2005","journal-title":"Stroke"},{"issue":"8","key":"10.1002\/14651858.CD005951.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa042991","article-title":"Recombinant activated factor VII for acute intracerebral hemorrhage","volume":"352","author":"Mayer","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005951.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1385\/NCC:4:3:206","article-title":"Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial","volume":"4","author":"Mayer","year":"2006","journal-title":"Neurocritical Care"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0011|cit11","doi-asserted-by":"crossref","unstructured":"Mayer SA Brun NC Begtrup K Broderick J Davis S Diringer MN Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage New England Journal of Medicine 2008 2127 37","DOI":"10.1056\/NEJMoa0707534"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0012|cit12","first-page":"7","article-title":"Tranexamic acid for acute intracerebral haemorrhage (TICH): results of the first randomised controlled trial","volume":"7","author":"Sprigg","year":"2012","journal-title":"International Journal of Stroke"},{"issue":"6","key":"10.1002\/14651858.CD005951.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.11.007","article-title":"Tranexamic acid for spontaneous intracerebral hemorrhage: a randomized controlled pilot trial","volume":"23","author":"Sprigg","year":"2014","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0014|cit14","unstructured":"Zazulia AR Antifibrinolytic therapy in acute intracerebral hemorrhage - ATICH www.strokecenter.org"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0015|cit15","unstructured":"Ciccone A Brambilla G Pozzi M Roccatagliata D Botto E Gruccione A Antifibrinolytic treatment of acute spontaneous intracerebral haemorrhage: rationale of the ANTITHESIS protocol Proceedings of the Italian Stroke Forum Florence, Italy 2007 Abst. EMORR_03"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/cc11923","article-title":"A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal","volume":"17","author":"Kerebel","year":"2013","journal-title":"Critical Care"},{"issue":"5","key":"10.1002\/14651858.CD005951.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11655-016-2467-7","article-title":"Activating blood circulation to remove stasis treatment of hypertensive intracerebral hemorrhage: a multi-center prospective randomized open-label blinded-endpoint trial","volume":"22","author":"Li","year":"2016","journal-title":"Chinese Journal of Integrative Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005951.pub4-BIB0018|cit18","first-page":"158","article-title":"Effect of Novoseven on hospitalization duration of Iranian ICH patients","volume":"25","author":"Madjdinasab","year":"2008","journal-title":"Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD005951.pub4-BIB0019|cit19","first-page":"233","article-title":"Auxiliary treatment of aprotinin on cerebral hemorrhage: clinical observation","volume":"20","author":"Meng","year":"2003","journal-title":"Journal of Apoplexy and Nervous Diseases"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0020|cit20","unstructured":"NCT00222625 rFVIIa in ICH in patients treated with anticoagulants or anti-platelets clinicaltrials.gov\/ct2\/show\/NCT00222625"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0021|cit21","unstructured":"NCT02429453 FFP versus PCC in intracranial hemorrhage clinicaltrials.gov\/ct2\/show\/NCT02429453"},{"issue":"6","key":"10.1002\/14651858.CD005951.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S1474-4422(16)00110-1","article-title":"Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial","volume":"15","author":"Steiner","year":"2016","journal-title":"Lancet Neurology"},{"issue":"1","key":"10.1002\/14651858.CD005951.pub4-BIB0023|cit23","first-page":"22","article-title":"Mechanism of aprotinin in auxiliary treatment of cerebral hemorrhage","volume":"38","author":"Zhou","year":"2005","journal-title":"Chinese Journal of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD005951.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"326-31","DOI":"10.1177\/1747493017694394","article-title":"Tranexamic acid for acute intracerebral hemorrhage growth predicted by spot sign trial: rationale and design","volume":"12","author":"Liu","year":"2017","journal-title":"International Journal of Stroke"},{"issue":"4","key":"10.1002\/14651858.CD005951.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"519-24","DOI":"10.1111\/ijs.12132","article-title":"The Spot sign and Tranexamic acid On Preventing ICH growth - AUStralasia Trial (STOP-AUST): protocol of a phase II randomized, placebo-controlled, double-blind,multicenter trial","volume":"9","author":"Meretoja","year":"2014","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0026|cit26","unstructured":"NCT00699621 Platelet transfusion in acute intracerebral hemorrhage clinicaltrials.gov\/ct2\/show\/NCT00699621"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0027|cit27","unstructured":"NCT00810888 The Spot Sign for predicting and treating ICH growth study (STOP-IT) clinicaltrials.gov\/ct2\/show\/NCT00810888"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0028|cit28","unstructured":"NCT01359202 'Spot Sign' selection of intracerebral hemorrhage to guide hemostatic therapy (SPOTLIGHT) clinicaltrials.gov\/ct2\/show\/NCT01359202"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0029|cit29","unstructured":"NCT02777424 Prothrombin complex concentrate versus fresh frozen plasma to correct coagulation disorders in adult neurosurgical patients (CLOT-CRANE) clinicaltrials.gov\/ct2\/show\/NCT02777424"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0030|cit30","unstructured":"NCT02866838 Treatment of Intracerebral Hemorrhage in Patients on Non-vitamin K Antagonist (TICH-NOAC) clinicaltrials.gov\/ct2\/show\/NCT02866838"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0031|cit31","unstructured":"NCT03044184 Tranexamic acid for spontaneous acute cerebral hemorrhage trial (TRANSACT) clinicaltrials.gov\/ct2\/show\/NCT03044184"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0032|cit32","unstructured":"The Norwegian Intracerebral Hemorrhage Trial (NOR-ICH) helseforskning.etikkom.no\/prosjekterirek\/prosjektregister\/prosjekt?p_document_id=324797"},{"issue":"6","key":"10.1002\/14651858.CD005951.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"717-23","DOI":"10.1177\/1747493016641960","article-title":"Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: protocol for a randomized, placebo-controlled trial","volume":"11","author":"Sprigg","year":"2016","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"b2586","DOI":"10.1136\/bmj.b2586","article-title":"Spontaneous intracerebral haemorrhage","volume":"339","author":"Al-Shahi Salman","year":"2009","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD005951.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.STR.28.1.1","article-title":"Early hemorrhage growth in patients with intracerebral hemorrhage","volume":"28","author":"Brott","year":"1997","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD005951.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/svn-2016-000047","article-title":"Current management of spontaneous intracerebral haemorrhage","volume":"2","author":"Dastur","year":"2017","journal-title":"Stroke and Vascular Neurology"},{"issue":"8","key":"10.1002\/14651858.CD005951.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1212\/01.wnl.0000208408.98482.99","article-title":"Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage","volume":"66","author":"Davis","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD005951.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1474-4422(09)70025-0","article-title":"Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review","volume":"8","author":"Feigin","year":"2009","journal-title":"Lancet Neurology"},{"issue":"3","key":"10.1002\/14651858.CD005951.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000441085","article-title":"Update on the global burden of ischemic and hemorrhagic stroke in 1990-2013: the GBD 2013 Study","volume":"45","author":"Feigin","year":"2015","journal-title":"Neuroepidemiology"},{"issue":"7","key":"10.1002\/14651858.CD005951.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","article-title":"Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"46","author":"Hemphill","year":"2015","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0041|cit41","unstructured":"Higgins JPT Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0042|cit42","unstructured":"Iorio Personal communication (email) 9th April 2012"},{"issue":"7","key":"10.1002\/14651858.CD005951.pub4-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010555.pub2","article-title":"Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients","author":"Johansen","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD005951.pub4-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004896.pub4","article-title":"Antifibrinolytic drugs for acute traumatic injury","author":"Ker","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD005951.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1474-4422(07)70107-2","article-title":"Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study","volume":"6","author":"Lovelock","year":"2007","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0046|cit46","unstructured":"Mayer SA Personal communication (discussion at the European Stroke Conference, Glasgow, UK 2007"},{"issue":"6","key":"10.1002\/14651858.CD005951.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/jnnp-2013-306476","article-title":"Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis","volume":"85","author":"Poon","year":"2014","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD005951.pub4-BIB0048|cit48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000200.pub2","article-title":"Surgery for primary supratentorial intracerebral haemorrhage","author":"Prasad","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0049|cit49","volume-title":"National Clinical Guideline for Stroke","author":"Intercollegiate Stroke Working Party","year":"2016"},{"issue":"3","key":"10.1002\/14651858.CD005951.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/STROKEAHA.114.007953","article-title":"Influence of intracerebral hemorrhage location on incidence, characteristics, and outcome: population-based study","volume":"46","author":"Samarasekera","year":"2015","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD005951.pub4-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005011.pub4","article-title":"Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia","author":"Simpson","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD005951.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/ijs.12309","article-title":"European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage","volume":"9","author":"Steiner","year":"2014","journal-title":"International Journal of Stroke"},{"issue":"8","key":"10.1002\/14651858.CD005951.pub4-BIB0053|cit53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008864.pub2","article-title":"Fibrinogen concentrate in bleeding patients","author":"Wikkels\u00f8","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0054|cit54","doi-asserted-by":"crossref","unstructured":"Zazulia Personal communication email 1, 15, 30 Nov 2005 2005","DOI":"10.1111\/j.2048-416X.2005.tb00086.x"},{"key":"10.1002\/14651858.CD005951.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.STR.0000251797.86897.a3","article-title":"Hemostatic drug therapies for acute, nontraumatic intracerebral hemorrhage","volume":"38","author":"Al-Shahi","year":"2007","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD005951.pub4-BIB0056|cit56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005951.pub3","article-title":"Haemostatic drug therapies for acute spontaneous intracerebral haemorrhage","author":"Al-Shahi Salman","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD005951.pub4-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005951.pub2","article-title":"Haemostatic drug therapies for acute primary intracerebral haemorrhage","author":"You","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd005951.pub5","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD005951.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T03:46:39Z","timestamp":1634701599000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005951.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Stroke Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,17]]},"references-count":57,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005951.pub4","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD005951.pub5","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,17]]}}}